AMPK activation increases uncoupling protein-3 expression and mitochondrial enzyme activities in rat muscle without fibre type transitions

  1. Charles T Putman*,
  2. Mónika Kiricsi*,
  3. Jean Pearcey*,
  4. Ian M MacLean*,
  5. Jeremy A Bamford*,
  6. Gordon K Murdoch,
  7. Walter T Dixon and
  8. Dirk Pette§
  1. *Exercise Biochemistry Laboratory, Faculty of Physical Education, University of Alberta
    Edmonton, AB, Canada T6G 2H9
  2. The Centre for Neuroscience, Faculty of Medicine and Dentistry, University of Alberta
    Edmonton, AB, Canada T6G 2H9
  3. Department of Agriculture, Food and Nutritional Science, University of Alberta
    Edmonton, AB, Canada T6G 2H9
  4. §Department of Biology, University of Konstanz
    Konstanz, Germany D-78457
  1. Corresponding author
    C. T. Putman: E-417 Van Vliet Centre, University of Alberta, Edmonton, Alberta, Canada T6G 2H9. Email: tputman{at}ualberta.ca

Abstract

The present study examined the effect of chronic activation of 5′-AMP-activated protein kinase (AMPK) on the metabolic profile, including uncoupling protein-3 (UCP-3) and myosin heavy chain (MHC)-based fibre phenotype of rodent fast-twitch tibialis anterior muscle. Sprague-Dawley rats were given daily injections of 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR), a known activator of AMPK, or vehicle (control) for 28 days. After AICAR treatment, UCP-3 expression at the mRNA level was elevated 1.6 ± 0.1-fold (P < 0.006) and corresponded to a 3.3 ± 0.2-fold increase in UCP-3 protein content (P < 0.0001). In addition, the activities of the mitochondrial reference enzymes citrate synthase (EC 4.1.3.7) and 3-hydroxyacyl-CoA-dehydrogenase (EC 1.1.1.35), which are known to increase in proportion to mitochondrial volume density, were elevated 1.6-fold (P < 0.006), while the activity of lactate dehydrogenase (EC 1.1.1.27) was reduced to 80 % of control (P < 0.02). No differences were detected after AICAR treatment in the activities of the glycolytic reference enzymes glyceraldehydephosphate dehydrogenase (EC 1.2.1.12) or phosphofructokinase (EC 2.7.1.11), nor were MHC-based fibre-type transitions observed, using immunohistochemical or electrophoretic analytical methods. These changes could not be attributed to variations in inter-organ signalling by metabolic substrates or insulin. We conclude that an AMPK-dependent pathway of signal transduction does mimic some of the metabolic changes associated with chronic exercise training, but does not affect expression of the MHC-based structural phenotype. Thus, the metabolic and MHC-based fibre types do not appear to be regulated in a co-ordinated way, but may be independently modified by different signalling pathways.

Footnotes

    • Received February 1, 2003.
    • Accepted May 29, 2003.
« Previous | Next Article »Table of Contents